A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis.
OBJECTIVE
To investigate the efficacy of two different high doses of intravenous methylprednisolone (IVMP) during Multiple Sclerosis (MS) relapses.


BACKGROUND
Transcranial Magnetic Stimulation (TMS) is the most sensitive neurophysiological ascertainment to quantify motor disability, to follow the recovery from an MS relapse, and to detect the response to treatment.


METHODS
Twenty-four clinically definite relapsing - remitting MS patients presenting a relapse were randomly assigned to a treatment for 5 days with IVMP 1 or 2 g/day. The response to treatment of each patient was evaluated through Expanded Disability Status Scale (EDSS), Medical Research Council (MRC) score, and TMS by means of motor evoked potential (MEP) parameters.


RESULTS
Motor threshold (MT), central motor conduction time (CMCT) and MRC showed a higher improvement with the highest dose of IVMP. Silent period and EDSS improved with both treatments.


CONCLUSIONS
The dose of 2 g/day of IVMP is more effective in MS relapse.
Fierro
B
B
Institute of Neuropsichiatry, University of Palermo, Palermo, Italy.
Salemi
G
G
Brighina
F
F
Buffa
D
D
Conte
S
S
La Bua
V
V
Piazza
A
A
Savettieri
G
G
D000328:Adult; D004305:Dose-Response Relationship, Drug; D019054:Evoked Potentials, Motor; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology; D009431:Neural Conduction; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D012008:Recurrence; D050781:Transcranial Magnetic Stimulation; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D008775:Methylprednisolone